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Methodological aspects of  prognostic
factor studies: some caveats
To the Editor: In this comment some
methodological aspects of prognostic factor studies are
discussed. Categorization of continuous variables should
be avoided and when necessary must be done before
applying a test. Confidence intervals give more precise
and clinically relevant information than p-values.
Statistical tests providing a maximum of test power should
be chosen. Repeated applications of the Cox model after
bootstrap resampling permit an estimation of the stability
of the model.
Recently Souto and co-workers1 created a new
scoring system for patients with myelodysplastic
syndromes.We would like to discuss some methodological
items of  this study.
Continuous variables were categorized by trial and
error until p-values were found close to 5%. It may be
useful to divide a continuous variable into categories, but
this is dangerous because categorizing means to a certain
degree “throwing away information”, or, if done by a data-
dependent approach, may increase substantially the type I
error rate. A better approach would be the use of univariate
Cox models for the continuous variables.2
The authors stress the importance of the p-value, e.g.
using the phrase “ the most significant prognostic factor”
P-values are only used to test whether the null hypothesis
should be rejected, thus indicating whether there is any
difference at all,  but are never an estimation of the amount
of the difference. A minimal difference may be statistically
significant but clinically without any importance.
Therefore confidence intervals of beta values of the
prognostic factors would have provided more precise
information than p-values.
According to Sanz’s work,3 the survival curves of
the variable hemoglobin were divided into three groups,
but no significant difference could be found, whereas this
was shown after dichotomization. We should not forget
that Sanz et al.3 analyzed a total of 370 patients, which
gives much more statistical power for detecting real
differences between the groups. Furthermore, when
comparing the survival curves of ordered groups (here:
hemoglobin), trend tests must be applied. Otherwise the
statistical power would be reduced, such that real
associations could be missed.
The final Cox model depends on the variables
initially offered, the rules determining the inclusion and
removal of variables, and the population selected. Since
in most statistical programs the user can choose between
several possibilities (e.g. between  conditional parameter
estimates, maximal partial likelihood estimates, Wald
statistics, or between foreward or backward selection etc.)
the calculation may result in different models. In stepwise
Cox regression the variables selected may be highly
unstable and other samples from the same population
might result in different models. A model formulated and
fitted to the same data, as in this case, is usually
“overfitted”.  Under ideal conditions the model should
be created by a “learning set” of data and than tested
with the data of other patients (“test set”), but this requires
a large number of patients. Alternatively, repeated
calculations of the Cox model based on a large number
of data sets obtained by bootstrap resampling of the
original 59 patients  would show the stability and
predictive ability of the model.4 A study based on 59
patients has a low test power and its results should at
best be regarded as hypothesis forming.
We do not understand why the variables E/M ratio
and WBC were included in the scoring system, since
neither of them had entered the multivariate Cox model
and therefore must be considered to be of no detectable
prognostic relevance. Moreover, we do not understand why
the authors divided the scoring system into exactly three
risk groups. Was this number suggested, for instance, by a
histogram or by a cluster analysis?
The above mentioned items should be clarified before
we can accept the new prognostic scoring system.
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In response: We would like to express our thanks
for the critical reading and valuable comments.
We do not agree with the point of view of the author of
these criticisms against the categorization of continuous
variables. Both the analysis using categorized variables and
the analysis using continuous variables encompass the use of
modeling for data representation. The model will be good or
not depending on how good it represents the relationship
under study. To categorize a continuous variable does not
imply necessarily losing important information, and the use
of more complex models does not guarantee automatically a
better representation of data. The analysis of tabular data is
an indispensable preliminary to modeling and can also serve
as a cross-check on modeling results.1 The procedure we used
can cause a significant increase in probability of type 1 error,
and we agree that it has to be avoided, but not for this reason.
This procedure should not be used because it can introduce
bias in the estimates, as it is done using this effect as the
criterion for choosing the category boundaries. There are other
ways to choose the cutpoints without introducing bias.
Regarding the emphasis on the use of the p-value we believe
the author of the criticisms has mixed up statements we made
in the paper with statistical concepts that have no relation to
our work. We agree that the use of confidence intervals to
present results is more informative than the use of p-values
and should be used often, following the trend of abandoning
the dichotomization imposed by the use of hypothesis testing,
in scientific inference. However his suggestion that we used
p-values ad should be used often, following a trend to abandon
the dichotomization imposed by the use of hypothesis testing
in scientific inference. However his suggestion that we used
p-values as a measure of effect size is not true. Just after the
statement he cites, “most significant prognostic factor”, we
presented the data with the description of the observed
differences in survival.
We also agree that a trend test should be used every
time we analyze ordered categorized variables, if the test
is available. And that was not the case when we did the
analysis. After the publication of the paper, the test was
done with no significant statistical differences.
Two score systems were developed, one based on
univariate analysis and the other based on multivariate
analysis, with agreement in the results. Because of space
limitation we chose to present only the table with results
based on the univariate analysis. The subjects were split
into three groups according to a histogram of the risk.
Any data set can generate a great number of different
analyses, depending on the degree of utilization of the
information in the sample, on the procedures the statistician
decides to use, and on other subjective decisions like the
degree of complexity of the analysis. In this case we decide
not to use couples procedures as the bootstrap.
We understand that the validity of our work is not
affected by the criticisms. Any scientific work, even when
using complex models in the analysis or a large sample
size, cannot have its results evaluated in an “accept or
reject” way. Any results can be potentially explained by
sample variability, model misspecification, misclas-
sification, bias, or mistakability, and they can also
correspond to a real association. Within the conditions
presented in the article and in these explanations, the results
should be weighed up and used as one more contribution
to the discussion leading to criteria for the prognostic
evaluation of MDS patients. We believe that additional
work in this field is neccessary in order to achieve reliable
score systems.
Elizabeth Xisto Souto
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